The Claim

In adults with type 2 diabetes receiving thyroxine, the presence of end-stage renal disease, coronary heart disease, heart failure, or cerebrovascular accident is associated with a substantially increased risk of major adverse cardiovascular events, independent of thyroid hormone levels.

Source: Risk factors and clinical implications of thyroxine replacement therapy on major adverse cardiovascular events in type 2 diabetes: a retrospective cohort study

What the research says

Supports is higher

Support is ahead, but a single strong opposing study can change this.

Supports
67score
Challenges
0score

These are independent scores, not a percentage. Higher-grade studies count more, so a single strong opposing study can outweigh several weaker ones.

Correlation
1 study reviewed
In plain English

Adults with type 2 diabetes who are taking thyroxine and have end-stage renal disease, coronary heart disease, heart failure, or a history of stroke have a higher rate of major cardiovascular events such as heart attack or stroke, regardless of their thyroid hormone levels.

See the scientific wording

In adults with type 2 diabetes receiving thyroxine, the presence of end-stage renal disease, coronary heart disease, heart failure, or cerebrovascular accident is associated with a substantially increased risk of major adverse cardiovascular events, independent of thyroid hormone levels.

Why this might work

When a person with type 2 diabetes already has severe kidney disease, heart disease, or a prior stroke, their blood vessels are already damaged and inflamed. This damage makes it harder for blood vessels to relax and increases the chance that fatty plaques will break open, triggering blood clots that cause heart attacks or strokes. Thyroxine improves some aspects of blood vessel health, but it cannot reverse the existing damage from these other diseases, so the risk of serious events remains high.

Supported mechanismbased on 1 study

What the research says

1 study

  1. Study: Risk factors and clinical implications of thyroxine replacement therapy on major adverse cardiovascular events in type 2 diabetes: a retrospective cohort study

    In people with type 2 diabetes taking thyroid hormone, those who already have kidney failure, heart disease, or a stroke are much more likely to have another serious heart or brain event—even if their thyroid levels are normal. The study found that these prior conditions, not thyroid levels, are what really raise the risk.

Score breakdown, mechanism chain, raw evidence, ideal studies needed & 1 supporting studies

Fit Body Science verdict — we translate health claims into clear verdicts backed by peer-reviewed research.

Not medical advice. For informational purposes only. Always consult a qualified healthcare professional before making health decisions.